Academic Journal
View in EDS

Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial

Bibliographic Details
Title: Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial
Authors: Atkins, Michael B *, Plimack, Elizabeth R, Puzanov, Igor, Fishman, Mayer N, McDermott, David F, Cho, Daniel C, Vaishampayan, Ulka, George, Saby, Olencki, Thomas E, Tarazi, Jamal C, Rosbrook, Brad, Fernandez, Kathrine C, Lechuga, Mariajose, Choueiri, Toni K
Source: In The Lancet Oncology March 2018 19(3):405-415
Database: ScienceDirect
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://www.doi.org/10.1016/S1470-2045(18)30081-0?
    Name: ScienceDirect (all content)-s8985755
    Category: fullText
    Text: View record from ScienceDirect
    MouseOverText: View record from ScienceDirect
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edselp&genre=article&issn=14702045&ISBN=&volume=19&issue=3&date=20180301&spage=405&pages=405-415&title=The Lancet Oncology&atitle=Axitinib%20in%20combination%20with%20pembrolizumab%20in%20patients%20with%20advanced%20renal%20cell%20cancer%3A%20a%20non-randomised%2C%20open-label%2C%20dose-finding%2C%20and%20dose-expansion%20phase%201b%20trial&aulast=Atkins%2C%20Michael%20B&id=DOI:10.1016/S1470-2045(18)30081-0
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
Header DbId: edselp
DbLabel: ScienceDirect
An: S1470204518300810
RelevancyScore: 1067
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 1067.29553222656
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Atkins%2C+Michael+B%22">Atkins, Michael B</searchLink> <superscript>*</superscript><br /><searchLink fieldCode="AR" term="%22Plimack%2C+Elizabeth+R%22">Plimack, Elizabeth R</searchLink><br /><searchLink fieldCode="AR" term="%22Puzanov%2C+Igor%22">Puzanov, Igor</searchLink><br /><searchLink fieldCode="AR" term="%22Fishman%2C+Mayer+N%22">Fishman, Mayer N</searchLink><br /><searchLink fieldCode="AR" term="%22McDermott%2C+David+F%22">McDermott, David F</searchLink><br /><searchLink fieldCode="AR" term="%22Cho%2C+Daniel+C%22">Cho, Daniel C</searchLink><br /><searchLink fieldCode="AR" term="%22Vaishampayan%2C+Ulka%22">Vaishampayan, Ulka</searchLink><br /><searchLink fieldCode="AR" term="%22George%2C+Saby%22">George, Saby</searchLink><br /><searchLink fieldCode="AR" term="%22Olencki%2C+Thomas+E%22">Olencki, Thomas E</searchLink><br /><searchLink fieldCode="AR" term="%22Tarazi%2C+Jamal+C%22">Tarazi, Jamal C</searchLink><br /><searchLink fieldCode="AR" term="%22Rosbrook%2C+Brad%22">Rosbrook, Brad</searchLink><br /><searchLink fieldCode="AR" term="%22Fernandez%2C+Kathrine+C%22">Fernandez, Kathrine C</searchLink><br /><searchLink fieldCode="AR" term="%22Lechuga%2C+Mariajose%22">Lechuga, Mariajose</searchLink><br /><searchLink fieldCode="AR" term="%22Choueiri%2C+Toni+K%22">Choueiri, Toni K</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: In <searchLink fieldCode="JN" term="%22The+Lancet+Oncology%22">The Lancet Oncology</searchLink> March 2018 19(3):405-415
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edselp&AN=S1470204518300810
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S1470-2045(18)30081-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 405
    Titles:
      – TitleFull: Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Atkins, Michael B
      – PersonEntity:
          Name:
            NameFull: Plimack, Elizabeth R
      – PersonEntity:
          Name:
            NameFull: Puzanov, Igor
      – PersonEntity:
          Name:
            NameFull: Fishman, Mayer N
      – PersonEntity:
          Name:
            NameFull: McDermott, David F
      – PersonEntity:
          Name:
            NameFull: Cho, Daniel C
      – PersonEntity:
          Name:
            NameFull: Vaishampayan, Ulka
      – PersonEntity:
          Name:
            NameFull: George, Saby
      – PersonEntity:
          Name:
            NameFull: Olencki, Thomas E
      – PersonEntity:
          Name:
            NameFull: Tarazi, Jamal C
      – PersonEntity:
          Name:
            NameFull: Rosbrook, Brad
      – PersonEntity:
          Name:
            NameFull: Fernandez, Kathrine C
      – PersonEntity:
          Name:
            NameFull: Lechuga, Mariajose
      – PersonEntity:
          Name:
            NameFull: Choueiri, Toni K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: March 2018
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 14702045
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: The Lancet Oncology
              Type: main
ResultId 1